CH Health Tech Advisory
Zurich
Executive advisory on scaling AI in healthcare, life science, and techbio. Working with corporate leadership, founders, and investors in healthtech AI and techbio.
Latest insights
Most AI-first techbios are modeling clinical costs that are roughly half of what they will actually face.
7 May 2026 · 3 min read
Three things I watch when reading any pharma AI announcement in 2026
5 May 2026 · 3 min read
FDA real-time clinical trials: the new regulatory data infrastructure layer
30 Apr 2026 · 3 min read